| Serum amyloid A in uremic HDL promotes inflammation T Weichhart, C Kopecky, M Kubicek, M Haidinger, D Döller, K Katholnig, ... Journal of the American Society of Nephrology 23 (5), 934-947, 2012 | 226 | 2012 |
| Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk S Zewinger, C Drechsler, ME Kleber, A Dressel, J Riffel, S Triem, ... European heart journal 36 (43), 3007-3016, 2015 | 174 | 2015 |
| Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells T Weichhart, M Haidinger, K Katholnig, C Kopecky, M Poglitsch, ... Blood, The Journal of the American Society of Hematology 117 (16), 4273-4283, 2011 | 155 | 2011 |
| Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation—a randomized, double-blind, placebo-controlled trial M Haidinger, J Werzowa, M Hecking, M Antlanger, G Stemer, J Pleiner, ... American Journal of Transplantation 14 (1), 115-123, 2014 | 138 | 2014 |
| Apoptotic cell-free DNA promotes inflammation in haemodialysis patients J Atamaniuk, C Kopecky, S Skoupy, MD Säemann, T Weichhart Nephrology Dialysis Transplantation 27 (3), 902-905, 2012 | 125 | 2012 |
| Empagliflozin in posttransplantation diabetes mellitus: a prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety E Schwaiger, L Burghart, L Signorini, R Ristl, C Kopecky, A Tura, G Pacini, ... American Journal of Transplantation 19 (3), 907-919, 2019 | 114 | 2019 |
| The versatility of HDL: a crucial anti‐inflammatory regulator MD Säemann, M Poglitsch, C Kopecky, M Haidinger, WH Hörl, ... European journal of clinical investigation 40 (12), 1131-1143, 2010 | 110 | 2010 |
| Dialysis modalities and HDL composition and function M Holzer, G Schilcher, S Curcic, M Trieb, S Ljubojevic, T Stojakovic, ... Journal of the American Society of Nephrology 26 (9), 2267-2276, 2015 | 90 | 2015 |
| Heart failure with preserved and reduced ejection fraction in hemodialysis patients: prevalence, disease prediction and prognosis M Antlanger, S Aschauer, C Kopecky, M Hecking, JJ Kovarik, J Werzowa, ... Kidney and Blood Pressure Research 42 (1), 165-176, 2017 | 77 | 2017 |
| Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition G Sharbeen, JA McCarroll, A Akerman, C Kopecky, J Youkhana, ... Cancer research 81 (13), 3461-3479, 2021 | 72 | 2021 |
| Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis C Kopecky, B Genser, C Drechsler, V Krane, CC Kaltenecker, ... Clinical Journal of the American Society of Nephrology 10 (2), 224-231, 2015 | 68 | 2015 |
| HDL cholesterol efflux does not predict cardiovascular risk in hemodialysis patients C Kopecky, S Ebtehaj, B Genser, C Drechsler, V Krane, M Antlanger, ... Journal of the American Society of Nephrology 28 (3), 769-775, 2017 | 56 | 2017 |
| Restoration of renal function does not correct impairment of uremic HDL properties C Kopecky, M Haidinger, R Birner-Grünberger, B Darnhofer, ... Journal of the American Society of Nephrology 26 (3), 565-575, 2015 | 49 | 2015 |
| Ex vivo culture of intact human patient derived pancreatic tumour tissue J Kokkinos, G Sharbeen, KS Haghighi, RMC Ignacio, C Kopecky, ... Scientific reports 11 (1), 1944, 2021 | 40 | 2021 |
| Molecular regulation of the renin–angiotensin system in haemodialysis patients JJ Kovarik, M Antlanger, O Domenig, CC Kaltenecker, M Hecking, ... Nephrology Dialysis Transplantation 30 (1), 115-123, 2015 | 36 | 2015 |
| Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus C Kopecky, Y Lytvyn, O Domenig, M Antlanger, JJ Kovarik, ... Diabetologia 62, 1090-1093, 2019 | 28 | 2019 |
| Critical role of neprilysin in kidney angiotensin metabolism CC Kaltenecker, O Domenig, C Kopecky, M Antlanger, M Poglitsch, ... Circulation Research 127 (5), 593-606, 2020 | 27 | 2020 |
| Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease M Antlanger, S Bernhofer, JJ Kovarik, C Kopecky, CC Kaltenecker, ... Annals of medicine 49 (6), 525-533, 2017 | 25 | 2017 |
| Post‐transplantation diabetes mellitus: evaluation of treatment strategies M Haidinger, M Antlanger, C Kopecky, JJ Kovarik, MD Säemann, ... Clinical transplantation 29 (5), 415-424, 2015 | 22 | 2015 |
| Comment on: HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events C Kopecky, T Weichhart, MD Saemann NEJM 372 (19), 1869, 2015 | 20* | 2015 |
